Statin-associated muscle injury

European Journal of Preventive Cardiology

Volumn 22, Issue 9, 2015, Pages 1161-

  Ballard, Kevin D ^a   Taylor, Beth A ^a   Thompson, Paul D ^a  

^a HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; BIOLOGICAL MARKER; CREATINE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CLINICAL TRIAL (TOPIC); HUMAN; LETTER; MUSCLE INJURY; MYALGIA; PERFORMANCE; PRIORITY JOURNAL; SKELETAL MUSCLE; BLOOD; CHEMICALLY INDUCED; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; METABOLISM; NORMAL HUMAN; PATHOLOGY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME FACTOR; UPREGULATION;

ATORVASTATIN CALCIUM; BIOMARKERS; CREATINE KINASE; DOUBLE-BLIND METHOD; HEALTHY VOLUNTEERS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MUSCLE, SKELETAL; MYALGIA; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; UP-REGULATION;

EID: 84938832023     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487315586096     Document Type: Letter

References (4)

1. Armitage J, Baigent C, Collins R,. Misrepresentation of statin safety evidence. Lancet 2014; 384: 1263-1264.
2. Collins R,. Lack of adverse effect of statin therapy on common muscle-related adverse events. Eur J Prev Cardiol. Epub ahead of print 23 June 2014. DOI:10.1177/2047487314541732.
3. Parker BA, Capizzi JA, Grimaldi AS,. Effect of statins on skeletal muscle function. Circulation 2013; 127: 96-103.
4. Ballard KD, Parker BA, Capizzi JA,. Increases in creatine kinase with atorvastatin treatment are not associated with decreases in muscular performance. Atherosclerosis 2013; 230: 121-124.